EU Warehouse

Tesamorelin

Tesamorelin is a stabilized growth hormone-releasing hormone analogue.

Loading …

ELVORA RESEARCH

Description

Randomized clinical trials and FDA labeling support an approved medicine for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. It is not indicated for general weight management, and long-term cardiovascular safety has not been established.

Research sources

External primary and regulatory sources for factual context. Not guidance on use.

Batch documents

Certificates of analysis

Verified batch-specific laboratory reports are linked here without alteration.

View all certificates
Not yet available

No verified COA is currently available for this product.

Continue through the catalogue

Explore more products.

Neutral Elvora product visual for Retatrutide
EU WarehousePrice

Retatrutide

Retatrutide is a clinical-stage triple agonist of the GIP, GLP-1 and glucagon receptors.

Neutral Elvora product visual for Tirzepatide
EU WarehousePrice

Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist.

Neutral Elvora product visual for BPC-157
EU WarehousePrice

BPC-157

BPC-157 is a synthetic pentadecapeptide studied in preclinical tissue and repair research.

Tesamorelin · ELVORA